{"name":"Provention Bio, a Sanofi Company","slug":"provention-bio-a-sanofi-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPdHlLSVFuMHlPdGtXekQ0QWFhaDNxS3ltOW5qWFNBM3hIU2VrdWZ6cDBWUGNuVHdFZGpTTWNpUkgwX29WbmhDNGNINHpIaURXb2pCQ0R2RGNYMXctMFluSXpmbVVERl8wY2FMQnd5bW5MU3ZBQWZRRTZuZHVicWgxTWZYZE5RQU5Gbml2VWhqdWtEUWpTcHc?oc=5","date":"2025-08-15","type":"pipeline","source":"Pharmaceutical Technology","summary":"Sanofi’s Tzield secures MHRA go-ahead for type 1 diabetes - Pharmaceutical Technology","headline":"Sanofi’s Tzield secures MHRA go-ahead for type 1 diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxONDFqYVEyb2IxR2ZKQ0F2Z19Od1ozbl9iTThoZ3dfMkYxVVVScFoycE5nVlNwWkhuZ3lDRUw0NTVpN3VHX3RPVFk3aTVaMkRvT3RseXNKSC1vV2NNMlpjc3d5MGRvSXotZVk5XzhNSTdxak0zWUdRajBBR0JJWkhjaHdGMlhPUXNmdjZjYnZ4OG1lUHN2d1hnazNRZ1JEVkFxYUE?oc=5","date":"2025-08-14","type":"regulatory","source":"BioPharm International","summary":"MHRA Approves Sanofi’s Teplizumab to Delay Onset of Stage III T1D - BioPharm International","headline":"MHRA Approves Sanofi’s Teplizumab to Delay Onset of Stage III T1D","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPbXFKZ0xmUVgzS0ZQQTROSmVXN05uNVd2aXFFSVY5Qi1aYjV3a1BfZGVsNjhGSnU5SVVwQ3R3NDg1RTZKSnlmQ1E0ajhqc0FUc1E3aEtTdGVEQVR1X2tQWEgtSFVTblNNQ1ZpbVhHM1ZrM2pLSFpxTkFneXRfRFNaWmhlZGtjRWtWLVZ5b0pHc2lDeE9vRTZFTEo4ektSYWM?oc=5","date":"2025-06-02","type":"pipeline","source":"Fierce Pharma","summary":"With Opella proceeds burning a hole in its pocket, Sanofi snaps up Blueprint for $9.1B - Fierce Pharma","headline":"With Opella proceeds burning a hole in its pocket, Sanofi snaps up Blueprint for $9.1B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPbUdkR21LVTZuQ0s5VVhvZXY0WktUNE4xWUNhZ25MWVRTVEktSng0U1pHNkJaRjFKTUxzdUxkTnlacDhjQjJtZ3N5Vnh1a29PTzh2WmZuQzFfU3pBekFMb0VvV2xycjBuMkV2Nk94ZEJlN2tIZDQ5ZG5KR1VoSWlmellUTHNsbHdpa1ZHTEZPejhCc2RsZ1JvcHgwcnVxQnpkOFd3WndGUnVNQQ?oc=5","date":"2023-03-16","type":"deal","source":"TechTarget","summary":"Sanofi Acquires Provention Bio for $2.9 Billion - TechTarget","headline":"Sanofi Acquires Provention Bio for $2.9 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNbkRNQ1BORHZTSkN6ajZhTFg5WFJKbjU1ZnZFQzlzanRvdmQ1WENOYXU4RFRKYWltWmNTRWVpYVpwUGhiNm1ERDJuM2REbERHVzNTdjdnaFpVbUVZUjMzWVF4eWxxMGtnLUhONW43Y1piTVVRamVRT0xwVlIxSWs2aFZtUktmVnBqZWppeU82NzRBc2hEQnZWcVFJYS0tVGw3d2ozNHBKNFlWdw?oc=5","date":"2023-03-13","type":"deal","source":"statnews.com","summary":"French pharma Sanofi buys maker of diabetes treatment for $2.9 billion - statnews.com","headline":"French pharma Sanofi buys maker of diabetes treatment for $2.9 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxONGRNTmdFRkk3cnlNbC1DQ1BVbmdhSW1uSGVtWUNDejdZVmZQakxoekEzaDFuMXdINlk4WjQ4QkRCT0x2WmlXRmo5b0x2WHhndldLaDBLUlFnMEtsUkNzNVUtRnAzdU5WNmVpcEdWQ2VURHF0WGgzQ0lhMC1qV255ZWduc1FfbGpvTGhIdUNpR2E?oc=5","date":"2023-03-13","type":"deal","source":"BioPharma Dive","summary":"Sanofi acquires diabetes drug via Provention buyout - BioPharma Dive","headline":"Sanofi acquires diabetes drug via Provention buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQMi1LNjF1TXFnYUFSRkRJTklTX25QeUJUQlhqSldIU0ptSmNMZVBhZE9jLWRlMzlnZVpDVmhJcDg2MXA5aS13aHFPQUo5ZDd2M0lUX0FYVU9xVDNhc3BvWVIzbk1qd2cxaHhRWTNRRFF2anltRFhNV19aUnJhWExIMWJ3UFpqMThI?oc=5","date":"2023-03-13","type":"pipeline","source":"Barron's","summary":"Provention Bio Stock Soars on $2.9 Billion Acquisition by Sanofi - Barron's","headline":"Provention Bio Stock Soars on $2.9 Billion Acquisition by Sanofi - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNVlBoQURZNUZWZnJpTXF0aEVKMmFGN0hBX3RQNXl4YjM2NndhVVp1Rk1KVElhZXBJNm9mQ1J3VXpWN3ltWW5na1lITFo1SXVHU19vYkw0ekJkM2F2ZEhiVVRGT1p5ZDBPN1V1dDhNaXU1V1RPTlpDdHdrcVZ5WWNMT2YtYW9rSEZDaXc?oc=5","date":"2023-03-13","type":"deal","source":"pharmaphorum","summary":"Sanofi buys Provention and diabetes drug Tzield for $2.9bn - pharmaphorum","headline":"Sanofi buys Provention and diabetes drug Tzield for $2.9bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPWHhTeVZMSmYxdGp6cE9jLVNaMXpzSzlFSThSdXBjNDdDazRwai1GQ2x3WmVhbkxUNGtrSjZMNzdQOWRVTE0wdVVUU3hXcjNoMnhKYU5pbFkzRHVVLTJrZFg4blBHTkVZZ2REYy01emI0aVFqWEQ1OFc0cUxvVzlObnhiUEhqdW40Zk4tVDBFYnFKcUtyMG5xWnRB?oc=5","date":"2023-03-13","type":"deal","source":"Fierce Pharma","summary":"Sanofi throws down $2.9B to acquire diabetes partner Provention Bio - Fierce Pharma","headline":"Sanofi throws down $2.9B to acquire diabetes partner Provention Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQWW1acTVKbW9QVW1QNDU1RC1WVVZEblpxX1J0T3Y5cEF6VUttRVRYM2UyYVh4RkNNdmZuVEVhb1M2alNnY3Eyd0Jac0hIU0p6cmo4ZjZxcG9WVHp2andyd3VZQmVKQ1daTkltNXNtNFo0VUhYaTN5blJKWi0tcWhyelpZSUtqUkdjQXBfV3ZtZldHWEJsa1hYNUQ4cTdZRmZfNHhzTUdiOXhRRGM?oc=5","date":"2023-02-14","type":"pipeline","source":"Contract Pharma","summary":"Provention Bio Completes $35M Equity Investment from Sanofi US - Contract Pharma","headline":"Provention Bio Completes $35M Equity Investment from Sanofi US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOMHBqR3p0ZHpvcV9FUGZaaWJvOVVmTm1vSjJLemUtbERfRmY1cFd2QWdnUjd3SUZLM2Vhd0RBd25pc0hUaDdkQ0tmWUw2XzAzMC1STDFTU1B0eUt0LTBLeUlnS2pESGhfMjVERmtwUTd1VzV3bVIxN29aQVpxak1wcTRrcFFjZTRSa01CSVBxZDlJNHh0ektQbmJVUktHZTJEbjQ0dzF1V1BQMHA0M28wbkJwMjJpeGtCVzlJTHFDNHc4aDk3ODNnU1VIRHNrZEprc1UwOQ?oc=5","date":"2023-02-13","type":"pipeline","source":"PR Newswire","summary":"Provention Bio Announces Completion of $35 Million Equity Investment from Sanofi US - PR Newswire","headline":"Provention Bio Announces Completion of $35 Million Equity Investment from Sanofi US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOWld2aTA0NnBVUGxjSnNyUXM5WFNPcGg4TGV6MnI5U3BTZHRLTmJmWHBLR2JYMEFGVDNWbWk4VVRrYlNuY0pJaTBqTkFIcHNPVmpLUld2VVJNa3B3OTNiR1FMSEYzMFpIQTdUdk10dFVPQzVBNGlhRVlUMGk3Wl8tWUVKSHpua0k1VzAxRUtKbnRmbFp0RjF1ZlF6Y1R4Q3UtSUVKaE1iR2JXR0JwVmV5SEJNTTJweGZPOVhVaQ?oc=5","date":"2022-11-17","type":"regulatory","source":"Reuters","summary":"U.S. FDA greenlights Provention Bio's diabetes drug - Reuters","headline":"U.S. FDA greenlights Provention Bio's diabetes drug","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}